Roth Capital Has Positive Forecast for ZVRA Q1 Earnings
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) – Stock analysts at Roth Capital lifted their Q1 2025 earnings per share (EPS) estimates for shares of Zevra Therapeutics in a research note issued to investors on Sunday, February 9th. Roth Capital analyst J. Aschoff now anticipates that the company will earn ($0.27) per share for the […]
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) – Stock analysts at Roth Capital lifted their Q1 2025 earnings per share (EPS) estimates for shares of Zevra Therapeutics in a research note issued to investors on Sunday, February 9th. Roth Capital analyst J. Aschoff now anticipates that the company will earn ($0.27) per share for the […]
